A new trading day began on Friday, with iBio Inc (NASDAQ: IBIO) stock price up 5.52% from the previous day of trading, before settling in for the closing price of $1.0. IBIO’s price has ranged from $0.56 to $6.89 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 64.37% over the past five years. Meanwhile, its annual earnings per share averaged 84.57%. With a float of $21.87 million, this company’s outstanding shares have now reached $22.49 million.
iBio Inc (IBIO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of iBio Inc is 2.74%, while institutional ownership is 25.62%. The most recent insider transaction that took place on Jan 10 ’25, was worth 25,000. In this transaction Chief Financial Officer of this company bought 9,191 shares at a rate of $2.72, taking the stock ownership to the 11,139 shares. Before that another transaction happened on Jan 10 ’25, when Company’s insider bought 9,191 for $2.72, making the entire transaction worth $25,000. This insider now owns 18,316 shares in total.
iBio Inc (IBIO) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.48 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 84.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 43.84% during the next five years compared to 64.37% growth over the previous five years of trading.
iBio Inc (NASDAQ: IBIO) Trading Performance Indicators
Here are iBio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 47.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.39, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of iBio Inc (IBIO)
iBio Inc (NASDAQ: IBIO) saw its 5-day average volume 1.24 million, a negative change from its year-to-date volume of 1.99 million. As of the previous 9 days, the stock’s Stochastic %D was 12.31%.
During the past 100 days, iBio Inc’s (IBIO) raw stochastic average was set at 39.38%, which indicates a significant increase from 11.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1436 in the past 14 days, which was higher than the 0.0928 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0630, while its 200-day Moving Average is $1.6177. Nevertheless, the first resistance level for the watch stands at $1.0930 in the near term. At $1.1360, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.2020. If the price goes on to break the first support level at $0.9840, it is likely to go to the next support level at $0.9180. The third support level lies at $0.8750 if the price breaches the second support level.
iBio Inc (NASDAQ: IBIO) Key Stats
With a market capitalization of 23.61 million, the company has a total of 22,487K Shares Outstanding. Currently, annual sales are 400 K while annual income is -18,380 K. The company’s previous quarter sales were 100 K while its latest quarter income was -5,720 K.
